World's Best Scientists 2026 revealed!
Gert Van Assche

Gert Van Assche

D-Index & Metrics

Medicine

D-Index
113
Citations
63749
World Ranking
4851
National Ranking
50

Overview

Gert Van Assche is affiliated with KU Leuven in Belgium and has a research profile strongly focused on inflammatory and autoimmune disorders, particularly inflammatory bowel disease (IBD). Their work spans several interconnected fields including medicine, biochemistry, genetics, and molecular biology.

The scientist's research output features a considerable emphasis on subfields such as genetics, epidemiology, surgery, immunology, and molecular biology. This multidisciplinary approach underpins investigations into complex disease mechanisms and treatment strategies.

Several main topics characterize their research:

  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Autoimmune and Inflammatory Disorders
  • IL-33, ST2, and ILC Pathways
  • Eosinophilic Esophagitis
  • Pharmacological Effects of Natural Compounds
  • Gastrointestinal Bleeding Diagnosis and Treatment

Gert Van Assche has contributed to numerous scientific publications, including recent papers such as:

  • "Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease" (2020), published in Gastroenterology
  • "Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update" (2020), published in Digestion
  • "Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies" (2020), published in Clinical Gastroenterology and Hepatology
  • "A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative Colitis" (2020), published in Inflammatory Intestinal Diseases
  • "Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium" (2020), published in Frontiers in Immunology

The publication venues where the scientist frequently publishes include:

  • Journal of Crohn's and Colitis
  • Gastroenterology
  • Clinical Gastroenterology and Hepatology
  • Inflammatory Intestinal Diseases
  • Scandinavian Journal of Gastroenterology

Collaborative work plays a significant role in Gert Van Assche's research, with frequent co-authors being:

  • Séverine Vermeire
  • Marc Ferrante
  • Gert De Hertogh
  • Brecht Creyns
  • Jan Ceuppens

Best Publications

  • Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.

    Filip Baert;Maja Noman;Severine Vermeire;Gert Van Assche

  • Vedolizumab as induction and maintenance therapy for ulcerative colitis.

    Brian G Feagan;Paul Rutgeerts;Bruce E Sands;Stephen Hanauer

  • 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

    Fernando Gomollón;Axel Dignass;Vito Annese;Herbert Tilg

  • Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

    L. Peyrin-Biroulet;W. Sandborn;B. E. Sands;W. Reinisch;W. Reinisch

  • Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD

    Marco Daperno;Geert D'Haens;Gert Van Assche;Filip Baert

  • Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

    Geert D'Haens;Filip Baert;Gert van Assche;Philip Caenepeel

  • Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

    Axel Dignass;James O. Lindsay;Andreas Sturm;Alastair Windsor

  • Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

    William J. Sandborn;Gert van Assche;Walter Reinisch;Jean–Frederic Colombel

  • The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

    Gert Van Assche;Axel Dignass;Julian Panes;Laurent Beaugerie

  • The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

    Gert Van Assche;Axel Dignass;Walter Reinisch;C. Janneke van der Woude

  • Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease

    Gert Van Assche;Marc Van Ranst;Raphael Sciot;Bénédicte Dubois

  • Second European Evidence-Based Consensus on the Diagnosis and Management of Ulcerative Colitis Part 1: Definitions and Diagnosis

    Axel Dignass;Rami Eliakim;Fernando Magro;Christian Maaser

  • Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.

    Julián Panés;Damián García-Olmo;Gert Van Assche;Jean Frederic Colombel

  • Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

    Geert D'Haens;Marc Ferrante;Severine Vermeire;Filip Baert

  • Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.

    Filip Baert;Liesbeth Moortgat;Gert Van Assche;Philip Caenepeel

  • Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease

    Niels Vande Casteele;Marc Ferrante;Gert Van Assche;Vera Ballet

  • Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn’s disease

    Severine Vermeire;Maja Noman;Gert van Assche;Filip Baert

  • Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

    Fabian Schnitzler;Herma Fidder;Marc Ferrante;Maja Noman

  • Development of the Crohn's disease digestive damage score, the Lémann score†‡§

    Benjamin Pariente;Jacques Cosnes;Silvio Danese;William J. Sandborn

  • Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

    David Laharie;Arnaud Bourreille;Julien Branche;Matthieu Allez

Frequent Co-Authors

Jan Ceuppens
Jan Ceuppens KU Leuven
Geert R. D'Haens
Geert R. D'Haens University of Amsterdam
Jean-Frederic Colombel
Jean-Frederic Colombel Icahn School of Medicine at Mount Sinai
William J. Sandborn
William J. Sandborn University of California, San Diego
Karel Geboes
Karel Geboes Ghent University Hospital
Frans Schuit
Frans Schuit KU Leuven
Walter Reinisch
Walter Reinisch Medical University of Vienna
Julián Panés
Julián Panés University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and complementary pathways in healthcare is a smart move for those interested in studying Medicine in the USA. Online degrees now make it easier to advance your career while managing costs and maintaining flexibility.

A popular choice is a mha degree cost-effective program, which prepares graduates for management and leadership roles in healthcare organizations. Another option is to explore the cheapest dnp programs, offering advanced practice and specialized clinical opportunities for nurses looking to achieve the highest level of nursing practice.

For those interested in pharmaceutical sciences, pursuing an online pharmacist degree can open doors to clinical, research, and retail settings. Additionally, the growing field of health informatics presents robust career opportunities—earning a him degree online is ideal for those interested in managing patient data and healthcare information systems.

These online programs offer flexible schedules, accessibility, and often lower tuition costs, making them attractive options for diverse career goals in the healthcare sector.

Best Scientists Citing Gert Van Assche

Trending Scientists

Recently Published Articles